|
| | | | | | | | | | | |
|
The Division of Drug Information (DDI) - serving the public by providing information on human drug products and drug product regulation by FDA
|
| | | |
| | | | | | | | | | | |
| |
FDA ’s Division of Drug Information has posted new Drug Safety Podcasts. Click on the following links to listen to podcasts and read the transcripts. |
| | | | |
| | | | | | | | | | | |
| |
- FDA adds Boxed Warning to highlight correct dosing of Ocaliva (obeticholic acid) for patients with a rare chronic liver disease
|
| | | | |
| | | | | | | | | | | |
| | |
| | |
| | | | | |
| | | | | | | | | | | |
| |
- FDA review finds additional data supports the potential for increased long-term risks with antibiotic clarithromycin (Biaxin) in patients with heart disease
|
| | | | |
| | | | | | | | | | | |
| | |
| |
|
No hay comentarios:
Publicar un comentario